Lik pls_老虎社区_美港股上老虎

2022-01-13

Lik pls

Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究表明，Fite 的 Piclidenoson 可以破坏病理性皮肤细胞吗</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":694429093,"tweetId":"694429093","gmtCreate":1642083573324,"gmtModify":1642083573600,"author":{"id":4097664093197460,"idStr":"4097664093197460","authorId":4097664093197460,"authorIdStr":"4097664093197460","name":"Chris_CHRIS","avatar":"https://static.tigerbbs.com/99bfc11e3279b5ee45705492228a37ee","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>Lik pls</p></body></html>","htmlText":"<html><head></head><body><p>Lik pls</p></body></html>","text":"Lik pls","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/694429093","repostId":1141565087,"repostType":4,"repost":{"id":"1141565087","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1642082533,"share":"https://www.laohunote.com/m/news/1141565087?lang=zh_CN&edition=full","pubTime":"2022-01-13 22:02","market":"us","language":"en","title":"Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究表明，Fite 的 Piclidenoson 可以破坏病理性皮肤细胞吗</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141565087","media":"Benzinga Earnings","summary":"Can-Fite BioPharma Ltd announced preclinical studies with skin cells, modeling psoriasis in humans, ","content":"<p><html><head></head><body><b>Can-Fite BioPharma Ltd</b> announced preclinical studies with skin cells, modeling psoriasis in humans, showing that Piclidenoson destroys pathological skin cells.</p><p><blockquote><html><head></head><body><b>Can-Fite生物制药有限公司</b>宣布了皮肤细胞的临床前研究，模拟人类银屑病，表明Piclidenoson破坏病理性皮肤细胞。</body></html></blockquote></p><p><ul><li>Piclidenoson is the company&#39;s lead drug candidate for the treatment of psoriasis.</li><li>The company&#39;s scientists reported that in the cell culture of human HaCaT cells, incubated with Piclidenoson, cell apoptosis was induced with an increase in the caspase protein, known to mediate apoptotic responses.</li><li>&#34;The data shown in our lab experiments are important and support the mechanism of action of Piclidenoson and supply additional support for the drug effect. We are encouraged by the positive interim analysis data reported last year based on 200 patients&#39; data and hope that it will be reproducible and that psoriasis patients will benefit from safety and long term relief from the symptoms of psoriasis,&#34; stated Can-Fite CEO Dr. Pnina Fishman.</li><li><b>Price Action:</b>CANF shares are up 2.24% at $1.37 during the premarket session on the last check Thursday.</li></ul></body></html></p><p><blockquote><ul><li>Piclidenoson是该公司治疗牛皮癣的主要候选药物。</li><li>该公司的科学家报告说，在与Piclidenoson孵育的人类HaCaT细胞的细胞培养中，随着caspase蛋白的增加诱导细胞凋亡，caspase蛋白已知介导凋亡反应。</li><li>“我们实验室实验中显示的数据很重要，支持了吡啶地诺松的作用机制，并为药物效果提供了额外的支持。我们对去年报告的基于200名患者数据的积极中期分析数据感到鼓舞，并希望它能够被复制，银屑病患者将从安全性和银屑病症状的长期缓解中受益，”Can-Fite首席执行官Pnina Fishman博士表示。</li><li><b>价格行为：</b>周四最后一次检查的盘前交易中，CANF 股价上涨 2.24%，至 1.37 美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究表明，Fite 的 Piclidenoson 可以破坏病理性皮肤细胞吗</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究表明，Fite 的 Piclidenoson 可以破坏病理性皮肤细胞吗</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2022-01-13 22:02</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><head></head><body><b>Can-Fite BioPharma Ltd</b> announced preclinical studies with skin cells, modeling psoriasis in humans, showing that Piclidenoson destroys pathological skin cells.</p><p><blockquote><html><head></head><body><b>Can-Fite生物制药有限公司</b>宣布了皮肤细胞的临床前研究，模拟人类银屑病，表明Piclidenoson破坏病理性皮肤细胞。</body></html></blockquote></p><p><ul><li>Piclidenoson is the company&#39;s lead drug candidate for the treatment of psoriasis.</li><li>The company&#39;s scientists reported that in the cell culture of human HaCaT cells, incubated with Piclidenoson, cell apoptosis was induced with an increase in the caspase protein, known to mediate apoptotic responses.</li><li>&#34;The data shown in our lab experiments are important and support the mechanism of action of Piclidenoson and supply additional support for the drug effect. We are encouraged by the positive interim analysis data reported last year based on 200 patients&#39; data and hope that it will be reproducible and that psoriasis patients will benefit from safety and long term relief from the symptoms of psoriasis,&#34; stated Can-Fite CEO Dr. Pnina Fishman.</li><li><b>Price Action:</b>CANF shares are up 2.24% at $1.37 during the premarket session on the last check Thursday.</li></ul></body></html></p><p><blockquote><ul><li>Piclidenoson是该公司治疗牛皮癣的主要候选药物。</li><li>该公司的科学家报告说，在与Piclidenoson孵育的人类HaCaT细胞的细胞培养中，随着caspase蛋白的增加诱导细胞凋亡，caspase蛋白已知介导凋亡反应。</li><li>“我们实验室实验中显示的数据很重要，支持了吡啶地诺松的作用机制，并为药物效果提供了额外的支持。我们对去年报告的基于200名患者数据的积极中期分析数据感到鼓舞，并希望它能够被复制，银屑病患者将从安全性和银屑病症状的长期缓解中受益，”Can-Fite首席执行官Pnina Fishman博士表示。</li><li><b>价格行为：</b>周四最后一次检查的盘前交易中，CANF 股价上涨 2.24%，至 1.37 美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CANF":"Can-Fite Biopharma Ltd"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141565087","content_text":"Can-Fite BioPharma Ltd announced preclinical studies with skin cells, modeling psoriasis in humans, showing that Piclidenoson destroys pathological skin cells.Piclidenoson is the company's lead drug candidate for the treatment of psoriasis.The company's scientists reported that in the cell culture of human HaCaT cells, incubated with Piclidenoson, cell apoptosis was induced with an increase in the caspase protein, known to mediate apoptotic responses.\"The data shown in our lab experiments are important and support the mechanism of action of Piclidenoson and supply additional support for the drug effect. We are encouraged by the positive interim analysis data reported last year based on 200 patients' data and hope that it will be reproducible and that psoriasis patients will benefit from safety and long term relief from the symptoms of psoriasis,\" stated Can-Fite CEO Dr. Pnina Fishman.Price Action:CANF shares are up 2.24% at $1.37 during the premarket session on the last check Thursday.","news_type":1,"symbols_score_info":{"CANF":0.9}},"isVote":1,"tweetType":1,"viewCount":1236,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/694429093"}